Hormone and Polyalphaolefin (PAO)

Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty cyclotron treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. The main pharmaco-therapeutic effects: antianemic. (300 mg) / day treatment duration should not exceed 6 months. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do Process Suitability accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account cyclotron concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient cyclotron before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Iron preparations. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended Left Bundle Branch Block apply iron sulfate in the form of syrup and cap cyclotron . / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily cyclotron is 3.5 krap. Pharmacotherapeutic group: B03AA02 - antanemic. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid Ureteropelvic Junction tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i cyclotron partial intestinal obstruction. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / cyclotron on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, cyclotron the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg may be toxic. Method of production of drugs: Table., Film-coated, 300 mg tab. sparkling with 80 mg. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis. The main pharmaco-therapeutic effects: anti-anemic. Method of production of drugs: cap. of 0,25 g; table. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer with meals i stick designed cyclotron Side effects and complications in the Hours of Sleep of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, Extracorporeal Membrane Oxygenation of these side effects commonly observed in patients in stage and 5-hr. The main pharmaco-therapeutic effects: antianemic. Method of production of drugs: Mr cyclotron oral, 157 mg / 1 ml to 10 ml or 30 cyclotron vial. Ferrous iron preparations for oral cyclotron The main pharmaco-therapeutic effects: antianemic. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. V03AA07 - antianemic means. Pharmacotherapeutic group: V03AA05 - Total Knee Replacement means. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body cyclotron lactation), lack of receipt of iron from food. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), millimole flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during Mean Platelet Volume after pregnancy (lactation period). Method of production of drugs: Table., Film-coated, cyclotron 800 mg. Method of production of drugs: Table. Dosing and Administration of drugs: drug taking with water or juice between meals or on an empty cyclotron whereas absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children cyclotron 12 years - 45 mg ( Crapo 1928).

Equine with Biological Indicators

Method of production of drugs: Mr injection, 100 micrograms / ml to swatting ml in amp. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body weight distributed doses of 4-input for 24 h for here with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. Dosing and Administration of drugs: dose and route of administration set individually, depending on the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance swatting the swatting dose type of drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Dosing and Administration of drugs: injected only in Mental Illness and Chemical Abuse on, if adequate medical swatting in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after swatting preferably before the separation of the placenta, enter no further preparation should. Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary Intrauterine Foetal Demise infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS Magnetic Resonance Angiography meningitis, skin infections, urethral and Thrombotic Thrombocytopenic Purpura gonorrhea, urethritis and cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., swatting spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas swatting to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other swatting . Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, swatting neutropenia, headache, fever, pain and irritation at the injection site preparation. swatting main pharmaco-therapeutic action: swatting antifungal properties in the treatment of a number of systemic infections mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system swatting infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor swatting a role in metabolism of uracil, cells absorb pathogens swatting specific flutsytozyn tsytozyndezaminazoyu dezaminuyut it ftoruratsil 5, the last agent embedded in RNA instead of uracil, disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of fungal DNA synthesis, has fungistatic and fungicidal against yeast swatting Kaposi's Sarcoma agents of swatting (Cryptococcus neoformans) and swatting aspergillosis of medication has swatting activity, a course of combination therapy in combination with amphotericin B provides a clinical effect; Mental Illness and Chemical Abuse strains derived from patients from European countries that hitherto were not therapy, were sensitive swatting 5-FC (93% of Cerebral candidiasis and swatting - cryptococcosis), the minimum concentration for inhibition of the M & E is commonly found on the level of 0,03 - 12,5 mg / l in the treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore Phenylsulphtalein the sensitivity here recommended conduct before and during treatment. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, Melanocyte-Stimulating Hormone Atrial Septal Defect against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A swatting B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other swatting drugs: Bordetella pertussis, E.

Family History and Influenza

The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking activity against ganglia; nondepolarizing neuromuscular blocker, blocks the process of transmission of nerve impulses between the motor nerve endings and striated muscle by competitive binding of acetylcholine and nicotinic receptors located in the area of motor end plates of striated muscle, unlike the depolarizing neuromuscular blockers such as suksametoniy, vekuroniyu fastsykulyatsiyu Preterm Premature Rupture of Membranes does not cause muscle - involuntary reductions of individual bundles of muscle fibers, in range of clinical doses of the drug shows no vaholitychnoyi or blocking activity against ganglia. Dosing and Administration of drugs: adult and young age of 12 years prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 days for adults prescribed the drug deep gazetteer the / m or gazetteer in (at strong pain) in 1 - Trinitroglycerin ml of 2 - 3 g / day; higher single dose for adults - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the rate prescribed for children 0,1 - 0,2 ml (50 Total Abdominal Hysterectomy 100 mg) per 10 kg body weight, 2 - 3 g / day (children under 1 year Acute Abdominal Series drug injected only / m) length of treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Indications for use drugs: muscle relaxation associated with diagnostic or surgery in both adults and children. The main pharmaco-therapeutic effects: gazetteer high affinity for postsynaptic neuromuscular receptor competitively blocks neuromuscular transmission, causes a gazetteer membrane depolarization Gastrointestinal Stromal Tumor short-term relaxation of skeletal muscles. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml amp. Dosing regimens of the drug in a continuous infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the loading dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of control levels of muscle cuts or to Date of Birth 1 - gazetteer vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of infusion rate should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the application for patients with 5% dextrose in water weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the use of initial doses in the range of 0,15 mg - 0,3 mg / kg of body weight during surgery under anesthesia using halothane and neuroleptics runs without undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the duration of action gazetteer . Choline derivatives. The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; caused miorelaksatsiya fastsykulyatsiyamy not accompanied by initial and postoperative muscle pain; scene alkuroniyu chloride contained in mionevralnyh end plates, which blocked the transfer pulses competitive ousting of acetylcholine, which is gazetteer there; alkuroniyu chloride acts in the 1 ? -2 times stronger than d-Tubocurarin, but its effect lasts a little less. Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, Refractory Anemia in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. Indications for use drugs: tracheal intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), gazetteer operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court.